1887

Abstract

PCV2 is a DNA virus that exists widely in pigs and has caused great economic losses to the pig industry worldwide. In the existing commercial PCV2 enzyme-linked immunosorbent assay (ELISA) kits both natural infection with PCV2 and vaccine immunization produce results that are positive for PCV2 Cap antibodies and therefore they cannot diagnose PCV2 infection in immunized pig farms.

To establish a PCV2 non-structural protein antibody detection method that distinguishes between antibodies resulting from natural prior exposure (infection) and those induced by subunit vaccine immunization.

Based on the non-structural Rep′ protein, we established an indirect ELISA (iELISA) using sera from guinea pigs and piglets.

The results for iELISA for guinea pig serum showed that animals vaccinated with a whole-virus inactivated PCV2 vaccine had 100 % (10/10) Cap antibody positivity and 100 % (10/10) Rep′ antibody positivity. Guinea pigs vaccinated with a recombinant subunit PCV2 vaccine had 100 % (10/10) Cap antibody positivity, while no (0/10) guinea pigs were Rep′ antibody-positive. The combined detection results for the Rep′ iELISA and a PCV2 Antibody Test kit (Commercial) showed that pigs vaccinated with a whole-virus inactivated PCV2 vaccine or PCV2 SD/2017 had 100 % (5/5) Cap antibody positivity and 100 % (5/5) Rep′ antibody positivity. Pigs vaccinated with a recombinant subunit PCV2 vaccine had 100 % (5/5) Cap antibody positivity, while no (0/10) pigs were Rep′ antibody-positive.

This paper describes an effective iELISA method that can distinguish natural infection with PCV2 (Cap and Rep positive) or inoculation with a whole-virus inactivated vaccine (Cap and Rep positive) from subunit vaccine immunization (Cap-positive, Rep-negative). These comparative assays could be very useful in the control of PCV2 in pig herds.

Funding
This study was supported by the:
  • Higher Education Comprehensive Award fund (Award 2018-702090250401)
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001230
2020-08-19
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/9/1183.html?itemId=/content/journal/jmm/10.1099/jmm.0.001230&mimeType=html&fmt=ahah

References

  1. Hamel AL, Lin LL, Nayar GP. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol 1998; 72:5262–5267 [View Article][PubMed]
    [Google Scholar]
  2. Meehan BM, McNeilly F, Todd D, Kennedy S, Jewhurst VA et al. Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J Gen Virol 1998; 79 (Pt 9:2171–2179 [View Article][PubMed]
    [Google Scholar]
  3. Phan TG, Giannitti F, Rossow S, Marthaler D, Knutson TP et al. Detection of a novel circovirus PCV3 in pigs with cardiac and multi-systemic inflammation. Virol J 2016; 13:184–191 [View Article][PubMed]
    [Google Scholar]
  4. Zhang HH, WQ H, JY L, Liu TN, Zhou JY et al. Novel circovirus species identified in farmed pigs designated as porcine circovirus 4, Hunan Province, China. Transbound Emerg Dis 2019
    [Google Scholar]
  5. Mankertz A, Mueller B, Steinfeldt T, Schmitt C, Finsterbusch T. New reporter gene-based replication assay reveals exchangeability of replication factors of porcine circovirus types 1 and 2. J Virol 2003; 77:9885–9893 [View Article][PubMed]
    [Google Scholar]
  6. Faurez F, Qiu WY, XH H. Replication of the porcine circovirus. Virol J 2009; 10:187
    [Google Scholar]
  7. Shuai J, Wei W, Jiang L, Li X, Chen N et al. Mapping of the nuclear localization signals in open reading frame 2 protein from porcine circovirus type 1. Acta Biochim Biophys Sin 2008; 40:71–77 [View Article][PubMed]
    [Google Scholar]
  8. Dupont K, Nielsen EO, Baekbo P, Larsen LE. Genomic analysis of PCV2 isolates from Danish Archives and a current PMWS case-control study supports a shift in genotypes with time. Vet Microbiol 2008; 128:56–64 [View Article][PubMed]
    [Google Scholar]
  9. Mukherjee P, Karam A, Barkalita L, Borah P, Chakraborty AK et al. Porcine circovirus 2 in the North eastern region of India: disease prevalence and genetic variation among the isolates from areas of intensive pig rearing. Acta Trop 2018; 182:166–172 [View Article][PubMed]
    [Google Scholar]
  10. Zhao GH, Cheng W, Zhang PJ, Han YS, Chen DK et al. Novel genotypes of type 2 porcine circovirus (PCV2) in PMWS pigs in China between 2008 and 2009. J Animal Vet Adv 2012; 9:3083–3091
    [Google Scholar]
  11. XL H, Liang HY, Zeng ZY, Tang DY, Wang B et al. Research progress of porcine circovirus. Swine Ind Sci 2018; 35:103–107
    [Google Scholar]
  12. SX W, Zeng Z, Cai JL, Liang WW, Lin L et al. Studies on molecular design, chemical synthesis and immunogenicity of novel antigenic peptides against the capsid protein of porcine circovirus type 2. Immunological J 2014; 30:397–401
    [Google Scholar]
  13. Beach NM, Meng X-J. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res 2012; 164:33–42 [View Article]
    [Google Scholar]
  14. Borel N, Bürgi E, Kiupel M, Stevenson GW, Mittal SK, Sydler T et al. [Three cases of postweaning multisystemic wasting syndrome (PMWS) due to porcine circovirus type 2 (PCV 2) in Switzerland]. Schweiz Arch Tierheilkd 2001; 143:249–255[PubMed]
    [Google Scholar]
  15. Gresham A, Giles N, Weaver J. PMWS and porcine dermatitis nephropathy syndrome in Great Britain. Vet Rec 2000; 147:115–121[PubMed]
    [Google Scholar]
  16. Xiao C-T, Harmon KM, Halbur PG, Opriessnig T. PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the U.S. during 2014-2016. Vet Microbiol 2016; 197:72–77 [View Article][PubMed]
    [Google Scholar]
  17. Darwich L, Mateu E, Laila D, Enric M. Immunology of porcine circovirus type 2 (PCV2). Virus Res 2012; 164:61–67 [View Article][PubMed]
    [Google Scholar]
  18. Wang XW, Zhao P, Wang LR, Liu XY, Hang BL. Progress in porcine circovirus type 2 immunology. Animal Husb Vet Med 2011; 43:94–97
    [Google Scholar]
  19. Pérez-Martín E, Grau-Roma L, Argilaguet JM, Nofrarías M, Escribano JM et al. Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs. J Virol Methods 2008; 154:167–174 [View Article][PubMed]
    [Google Scholar]
  20. Liu D, Wang YP, Wei YW, Tang QH, HL W et al. Determ ination of immunogenicity and neutralizing activity of the Rep and Rep′ proteins derived from porcine circovirus type 2. Chinese vet sci 2012; 12:1216–1223
    [Google Scholar]
  21. Shang S-B, Li Y-F, Guo J-Q, Wang Z-T, Chen Q-X et al. Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2. Res Vet Sci 2008; 84:150–157 [View Article]
    [Google Scholar]
  22. Wu P-C, Chien M-S, Tseng Y-Y, Lin J, Lin W-L et al. Expression of the porcine circovirus type 2 capsid protein subunits and application to an indirect ELISA. J Biotechnol 2008; 133:58–64 [View Article][PubMed]
    [Google Scholar]
  23. Zhao W, Sun GZ. Commonly used random grouping method for experimental animals. Chinese J Animal Husb Vet Med 2009; 4:61–62
    [Google Scholar]
  24. Gao C, Gao YH, Yao NQ, GX H. Establishment of an indirect ELISA with PCV2 recombinant capsid protein expressed in E. coli and initial application. Chinese J of Vet Sci 2008; 28:888–891
    [Google Scholar]
  25. Huang LP, Liu CM, Wei YW, YH L, Guo LJ. Establishment and application of blocking ELISA detection method for porcine circovirus type 2 serum neutralizing antibody. Vet Sci in China 2009; 39:779–785
    [Google Scholar]
  26. Shang S-B, Li Y-F, Guo J-Q, Wang Z-T, Chen Q-X et al. Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2. Res Vet Sci 2008; 84:150–157 [View Article][PubMed]
    [Google Scholar]
  27. Walker IW, Konoby CA, Jewhurst VA, McNair I, McNeilly F et al. Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. J Vet Diagn Invest 2000; 12:400–405 [View Article][PubMed]
    [Google Scholar]
  28. Blanchard P, Mahé D, Cariolet R, Truong C, Le Dimna M et al. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome. Vet Microbiol 2003; 94:183–194 [View Article][PubMed]
    [Google Scholar]
  29. Nawagitgul P, Harms PA, Morozov I, Thacker BJ, Sorden SD et al. Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV. Clin Diagn Lab Immunol 2003; 9:33–40
    [Google Scholar]
  30. Nainys J, Lasickiene R, Petraityte-Burneikiene R, Dabrisius J, Lelesius R et al. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. BMC Biotechnol 2014; 14:100 [View Article][PubMed]
    [Google Scholar]
  31. Martin H, Le Potier M-F, Maris P. Virucidal efficacy of nine commercial disinfectants against porcine circovirus type 2. Vet J 2008; 177:388–393 [View Article][PubMed]
    [Google Scholar]
  32. O'Dea MA, Hughes AP, Davies LJ, Muhling J, Buddle R et al. Thermal stability of porcine circovirus type 2 in cell culture. J Virol Methods 2008; 147:61–66 [View Article][PubMed]
    [Google Scholar]
  33. Rong J, BJ X, Guo WW, Kuang HY. Establishment of guinea pigs model for efficacy evaluation of porcine circovirus type 2 vaccines. Chinese J Prev Vet Med 2016; 38:479–483
    [Google Scholar]
  34. Tang J, Bao J, Meng C, Zhang Z. Confirmation and analysis of the cut-off value in hepatitis C antibody determined by ELISA with receiver operating characteristic curve. Lab Med 2014; 29:826–830
    [Google Scholar]
  35. Lu X, Cheng J, Bao J, Zhang Z, Zhang L et al. The determination of optimal cut-off value and its dubious interval for detection of anti-HCV antibody by ELISA. Modern Preventive Med 2015; 42:1841–1844
    [Google Scholar]
  36. Wang XL, Mao KR, Cheng JS, Zhang LC, Ding JB et al. Establishment and application of an indirect ELISA for Brucella antibody detection in goats and sheep. Chinese J of Vet Drug 2013; 47:40–45
    [Google Scholar]
  37. Li X, Li D-Q, Zhao P, Cui Z-Z. [The ALV-A/B specific antibodies correlation between ELISA and IFA detection in chicken serum]. Bing Du Xue Bao 2012; 28:615–620[PubMed]
    [Google Scholar]
  38. Yang H, Fang LR, Dong Nan LJ, Qian J et al. Development and evaluation of an indirect ELISA based on recombinant nucleocapsid protein for detecting antibodies against porcine deltacoronavirus. Microbiol China 2017; 44:2830–2838
    [Google Scholar]
  39. Chen J-Y, Wu C-M, Liao C-M, Chen K-C, You C-C et al. The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications. Vaccine 2019; 37:6535–6542 [View Article][PubMed]
    [Google Scholar]
  40. Mankertz A, Çaliskan R, Hattermann K, Hillenbrand B, Kurzendoerfer P et al. Molecular biology of porcine circovirus: analyses of gene expression and viral replication. Vet Microbiol 2004; 98:81–88 [View Article][PubMed]
    [Google Scholar]
  41. Segalés J, Allan GM, Domingo M. Porcine circovirus diseases. Anim Health Res Rev 2005; 6:119–142 [View Article][PubMed]
    [Google Scholar]
  42. Calsamiglia M, Segalés J, Quintana J, Rosell C, Domingo M. Detection of porcine circovirus types 1 and 2 in serum and tissue samples of pigs with and without postweaning multisystemic wasting syndrome. J Clin Microbiol 2002; 40:1848–1850 [View Article][PubMed]
    [Google Scholar]
  43. Rodríguez-Arrioja GM, Segalés J, Balasch M, Rosell C, Quintana J et al. Serum antibodies to porcine circovirus type 1 (PCV-1) and type 2 (PCV-2) in pigs with and without postweaning multisystemic wasting syndrome (PMWS). Vet Rec 2000; 146:762–764
    [Google Scholar]
  44. Ellis J, Hassard L, Clark E, Harding J, Allan G et al. Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J 1998; 39:44–51[PubMed]
    [Google Scholar]
  45. Olvera A, Cortey M, Segalés J. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virol 2007; 357:175–185 [View Article][PubMed]
    [Google Scholar]
  46. Wu Y, Zhang H, Wang XY, Bao WH, Fan HJ. Molecular epidemiological investigation of porcine circovirus type 2 (PCV2) in Zhejiang Province and surrounding areas. J Agric Biotech 2013; 21:456–463
    [Google Scholar]
  47. Cao DY, Wang XM, Qian AD, KW H, Mao AH. Molecular epidemiological investigation of porcine circovirus type 2(PCV2) in Jiangsu and surrounding areas. J Agric Sci 2016; 32:390–398
    [Google Scholar]
  48. Zheng G, Lu Q, Wang F, Xing G, Feng H et al. Phylogenetic analysis of porcine circovirus type 2 (PCV2) between 2015 and 2018 in Henan Province, China. BMC Vet Res 2020; 16:6–16 [View Article][PubMed]
    [Google Scholar]
  49. CY L, Liu MX, Chen SY, Yuan XQ, Xing D et al. Establishment of an indirect ELISA for the detection of antibodies against PCV2 based on recombinant ORF3 protein. Chinese J Vet Sci 2017; 04:29–36
    [Google Scholar]
  50. Janz JAM, Morel PCH, Wilkinson BHP, Purchas RW. Preliminary investigation of the effects of low-level dietary inclusion of fragrant essential oils and oleoresins on pig performance and pork quality. Meat Sci 2007; 75:350–355 [View Article][PubMed]
    [Google Scholar]
  51. Liu J, Chen I, Kwang J. Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol 2005; 79:8262–8274 [View Article][PubMed]
    [Google Scholar]
  52. Liu J, Chen I, Du Q, Chua H, Kwang J. The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo. J Virol 2006; 80:5065–5073 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001230
Loading
/content/journal/jmm/10.1099/jmm.0.001230
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL

Supplementary material 3

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error